Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication

NCT06811207 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG: Vonoprazan
DRUG: Esomeprazole 40mg
DRUG: Amoxicillin

Sponsor

Chang Gung Memorial Hospital